Cornerstone Advisors Asset Management, Inc Abb Vie Inc. Transaction History
Cornerstone Advisors Asset Management, Inc
- $452 Billion
- Q3 2024
A detailed history of Cornerstone Advisors Asset Management, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cornerstone Advisors Asset Management, Inc holds 2,500 shares of ABBV stock, worth $424,075. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$424,075% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,837Shares Held
1.25BCall Options Held
15.7MPut Options Held
11.3M-
Vanguard Group Inc Valley Forge, PA172MShares$29.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.84 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.57 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $300B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...